Technical analysis of Forte Biosciences, Inc. (FBRX): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Forte Biosciences, Inc. is a U.S.-based biopharmaceutical company currently in its clinical development phase. The firm's key initiative involves advancing the FB-102 program, which is designed to tackle a variety of autoimmune conditions, notably vitiligo and alopecia areata. Their main offices are situated in Dallas, Texas.
Price Performance
| 1 month | +0.14% |
| 3 months | +331.32% |
| Year-to-date | +182.32% |
| 1 year | +543.73% |
| 3 years | +296.86% |
| 5 years | -14.46% |
52-Week Range
| 52-week High | $77.20 |
| 52-week Low | $10.11 |
| Avg Volume (90d) | 1.0M |
Technical Indicators
| SMA 50 | $53.93 |
| SMA 200 | $32.54 |
| Beta | 3.20 |
| 30-day Volatility (annualised) | 107.0% |
| Price vs SMA 50 | +42.8% |
| Price vs SMA 200 | +136.6% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $12.94 | |
| 2025-11 | $18.56 | +43.4% |
| 2025-12 | $27.27 | +46.9% |
| 2026-01 | $29.27 | +7.3% |
| 2026-02 | $30.22 | +3.2% |
| 2026-03 | $25.90 | -14.3% |
| 2026-04 | $26.66 | +2.9% |
| 2026-05 | $19.07 | -28.5% |
| 2026-06 | $21.25 | +11.4% |
| 2026-07 | $76.60 | +260.5% |
| 2026-08 | $76.99 | +0.5% |
Price
| Price | $76.99 |
| Market Cap | $1.6B |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 9.96 |
| EV / EBITDA | -17.71 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.00 |
| Current Ratio | 10.01 |